RHOEN-KLINIKUM AG (RHK.DE) Stock Fundamental Analysis
Europe • Frankfurt Stock Exchange • FRA:RHK • DE0007042301
13.2 EUR
+0.1 (+0.76%)
Last: Jan 30, 2026, 07:00 PM
RHK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 33 industry peers in the Health Care Providers & Services industry. RHK is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. While showing a medium growth rate, RHK is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
- In the past year RHK was profitable.
- RHK had a positive operating cash flow in the past year.
- Each year in the past 5 years RHK has been profitable.
- In the past 5 years RHK always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of RHK (2.02%) is comparable to the rest of the industry.
- RHK's Return On Equity of 2.90% is on the low side compared to the rest of the industry. RHK is outperformed by 63.64% of its industry peers.
- RHK has a worse Return On Invested Capital (2.67%) than 69.70% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for RHK is below the industry average of 5.90%.
- The last Return On Invested Capital (2.67%) for RHK is above the 3 year average (2.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.02% | ||
| ROE | 2.9% | ||
| ROIC | 2.67% |
ROA(3y)2%
ROA(5y)1.56%
ROE(3y)2.83%
ROE(5y)2.2%
ROIC(3y)2.34%
ROIC(5y)2.01%
1.3 Margins
- With a Profit Margin value of 2.28%, RHK perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
- RHK's Profit Margin has declined in the last couple of years.
- With a Operating Margin value of 2.86%, RHK is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
- RHK's Operating Margin has declined in the last couple of years.
- The Gross Margin of RHK (66.81%) is better than 72.73% of its industry peers.
- In the last couple of years the Gross Margin of RHK has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.86% | ||
| PM (TTM) | 2.28% | ||
| GM | 66.81% |
OM growth 3Y11.39%
OM growth 5Y-7.03%
PM growth 3Y10.42%
PM growth 5Y-3.92%
GM growth 3Y-1.4%
GM growth 5Y-0.67%
2. Health
2.1 Basic Checks
- RHK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, RHK has about the same amount of shares outstanding.
- Compared to 5 years ago, RHK has about the same amount of shares outstanding.
- The debt/assets ratio for RHK has been reduced compared to a year ago.
2.2 Solvency
- RHK has an Altman-Z score of 3.09. This indicates that RHK is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 3.09, RHK belongs to the best of the industry, outperforming 87.88% of the companies in the same industry.
- RHK has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
- Looking at the Debt to Equity ratio, with a value of 0.09, RHK belongs to the top of the industry, outperforming 96.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 3.09 |
ROIC/WACC0.4
WACC6.63%
2.3 Liquidity
- RHK has a Current Ratio of 2.28. This indicates that RHK is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 2.28, RHK belongs to the top of the industry, outperforming 93.94% of the companies in the same industry.
- A Quick Ratio of 2.19 indicates that RHK has no problem at all paying its short term obligations.
- RHK's Quick ratio of 2.19 is amongst the best of the industry. RHK outperforms 93.94% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.28 | ||
| Quick Ratio | 2.19 |
3. Growth
3.1 Past
- The earnings per share for RHK have decreased strongly by -15.41% in the last year.
- RHK shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.03% yearly.
- RHK shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.10%.
- Measured over the past years, RHK shows a small growth in Revenue. The Revenue has been growing by 4.12% on average per year.
EPS 1Y (TTM)-15.41%
EPS 3Y15.28%
EPS 5Y0.03%
EPS Q2Q%3.33%
Revenue 1Y (TTM)9.1%
Revenue growth 3Y4.41%
Revenue growth 5Y4.12%
Sales Q2Q%8.37%
3.2 Future
- Based on estimates for the next years, RHK will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.57% on average per year.
- RHK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.93% yearly.
EPS Next Y4.3%
EPS Next 2Y10.47%
EPS Next 3Y11.09%
EPS Next 5Y11.57%
Revenue Next Year6.74%
Revenue Next 2Y5.36%
Revenue Next 3Y6.5%
Revenue Next 5Y5.93%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 23.16, which indicates a rather expensive current valuation of RHK.
- Based on the Price/Earnings ratio, RHK is valued a bit more expensive than the industry average as 60.61% of the companies are valued more cheaply.
- RHK is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.32, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 17.27, the valuation of RHK can be described as rather expensive.
- Based on the Price/Forward Earnings ratio, RHK is valued a bit more expensive than 63.64% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of RHK to the average of the S&P500 Index (25.57), we can say RHK is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.16 | ||
| Fwd PE | 17.27 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RHK indicates a rather cheap valuation: RHK is cheaper than 96.97% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 0.57 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.38
PEG (5Y)680.99
EPS Next 2Y10.47%
EPS Next 3Y11.09%
5. Dividend
5.1 Amount
- RHK has a yearly dividend return of 0.76%, which is pretty low.
- RHK's Dividend Yield is comparable with the industry average which is at 1.60.
- With a Dividend Yield of 0.76, RHK pays less dividend than the S&P500 average, which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.76% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 17.78% of the earnings are spent on dividend by RHK. This is a low number and sustainable payout ratio.
DP17.78%
EPS Next 2Y10.47%
EPS Next 3Y11.09%
RHOEN-KLINIKUM AG / RHK.DE FAQ
Can you provide the ChartMill fundamental rating for RHOEN-KLINIKUM AG?
ChartMill assigns a fundamental rating of 5 / 10 to RHK.DE.
What is the valuation status of RHOEN-KLINIKUM AG (RHK.DE) stock?
ChartMill assigns a valuation rating of 2 / 10 to RHOEN-KLINIKUM AG (RHK.DE). This can be considered as Overvalued.
Can you provide the profitability details for RHOEN-KLINIKUM AG?
RHOEN-KLINIKUM AG (RHK.DE) has a profitability rating of 4 / 10.
Can you provide the financial health for RHK stock?
The financial health rating of RHOEN-KLINIKUM AG (RHK.DE) is 7 / 10.
How sustainable is the dividend of RHOEN-KLINIKUM AG (RHK.DE) stock?
The dividend rating of RHOEN-KLINIKUM AG (RHK.DE) is 2 / 10 and the dividend payout ratio is 17.78%.